Cite
HARVARD Citation
Ascierto, P. et al. (n.d.). EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). European journal of cancer. pp. S128-. [Online].